Pasteur in Biological Technology

Sanofi-aventis Announces Second Quarter 2009 Results

... and Drug Administration licensed the new sanofi pasteur influenza vaccine manufacturing facility in ... influenza vaccine per year. Sanofi pasteur received several orders to produce a vaccine ... as a contract from the French government. Sanofi pasteur is in discussion with several other governments ...

Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply

... vaccine from the market. Since that time, Sanofi pasteur has been, and continues to be, the sole supplier of Hib vaccine to the U.S. market. Sanofi pasteur is able to meet the nation's need for Hib ... Vaccine [Tetanus Toxoid Conjugate]). "Sanofi pasteur has accelerated production and reallocated excess ...

Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine

... committed to protecting human health, Sanofi pasteur looks forward to quickly understanding how this ... Receipt of the seed virus means that Sanofi pasteur will begin the development process, called ... two weeks. Following quality controls, Sanofi pasteur will be prepared to begin industrial production ...

The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases

... PARIS, May 18 /PRNewswire/ -- The Institut pasteur and Merieux Alliance have signed a letter of ... research partnership. The Institut pasteur and Merieux Alliance (which comprises the ... follows an agreement signed between the Institut pasteur and the Fondation Merieux on April 14th, aimed at ...

Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants

... Sanofi pasteur and Chumakov Institute Russian Academy Medical ... inactivated polio vaccine (IPV) from Sanofi pasteur for primary immunization of all infants. The IPV ... to IPV in a tropical setting, for which sanofi pasteur is donating 1.5 million doses of IPV over 5 ....

RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster

... Paris (EURONEXT: SAN and NYSE: SNY), and Louis pasteur University of Strasbourg, France, to develop the ... and Supramolecular Engineering (ISIS) in Louis pasteur University, and RainDance Technologies' unique ... http://www.raindancetech.com . About Louis pasteur University ...

Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season

... challenges, we are pleased that once again sanofi pasteur has demonstrated its reliability in ... "The early shipment of Fluzone vaccine by sanofi pasteur gives health-care providers greater flexibility ... for the 2007-2008 influenza season. Sanofi pasteur is committed to raising immunization rates and ...

U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile

... and manufacturing of influenza vaccine, sanofi pasteur is actively involved in projects in the U.S. and ... pandemic influenza virus. In June 2007, sanofi pasteur completed construction of a new manufacturing ... when it begins production in early 2009. Sanofi pasteur leads the way in pandemic preparedness with ...

Sanofi Pasteur Mounts Emergency Response to Yellow Fever Epidemic in Latin America

... requests from Health Authorities. "Sanofi pasteur mobilized its teams to make this public ... which is reserved for outbreak responses. Sanofi pasteur is currently the only vaccine supplier to the UNICEF yellow fever vaccine stockpile. Sanofi pasteur is the largest provider of yellow fever ...

Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis

... terms of the agreement, SSI has granted sanofi pasteur a license to its technology with regard to the ... If the development is successful, sanofi pasteur would manufacture the vaccine commercially. SSI ... to provide a positive immune response. Sanofi pasteur intends to build on the successes of the SSI ...

Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage

... fully developed, this vaccine should give sanofi pasteur the potential to provide billions of doses in a ... variants of the H5N1 strains is ongoing. Sanofi pasteur has committed, in the event of a pandemic being ... doses of influenza vaccine in 2006, sanofi pasteur confirmed its leadership as the world's largest ...

Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases

... bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/ Harvard Medical School . A privately held company based in Cambridge, Massachusetts, ...

CBDM.T, The Market and Business Intelligence Company Reviews The Vaccine Market

... and provide immunity against one or several diseases. The vaccination was first used by Edward Jenner in 1796 against smallpox and furthered by Louis pasteur in the 1870's. Vaccines are developed from whole dead or attenuated organisms, pathogen protein toxin (toxoids), pathogen surface molecules, ...

RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference

... a wide variety of growing life sciences and applied sciences markets. "We have announced a consortium with sanofi aventis and Universite Louis pasteur to develop the next generation of high-throughput screening and small molecule compound storage for drug discovery -- a $4 billion market," said ...

Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth

... President of Training & Education for Computer Motion Inc., the world initiator of medical robotics. Dr. Zanganeh received her degree from Louis pasteur University in Strasbourg, France and her MBA from Schiller International University in France. She is fluent in French, German, Persian & ...

French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees)

... sustainability. About AMP The Agence de Medecine Preventive is a not-for-profit organization, with headquarters at the Institut pasteur in Paris, and offices in Benin, Burkina Faso, Cote d'Ivoire and Senegal. Its mission is to promote preventive medicine in the field of vaccinology ...

Cequent Names Ted Hibben Chief Business Officer

... bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/ Harvard Medical School . A privately held company based in Cambridge, Massachusetts, ...

Tips from the journals of the American Society for Microbiology

... and Environmental Microbiology, 74. 16: 5047-5052.) New Oral Vaccine May Protect Against Bubonic Plague Researchers from the Institut pasteur in Paris, France used a less virulent ancestor to the highly infectious bubonic plague to develop a potentially safe, efficient and inexpensive live ...

Tips from the journals of the American Society for Microbiology

... and Environmental Microbiology, 74. 16: 5047-5052.) New Oral Vaccine May Protect Against Bubonic Plague Researchers from the Institut pasteur in Paris, France used a less virulent ancestor to the highly infectious bubonic plague to develop a potentially safe, efficient and inexpensive live ...

Tips from the journals of the American Society for Microbiology

... and Environmental Microbiology, 74. 16: 5047-5052.) New Oral Vaccine May Protect Against Bubonic Plague Researchers from the Institut pasteur in Paris, France used a less virulent ancestor to the highly infectious bubonic plague to develop a potentially safe, efficient and inexpensive live ...

Inaugural Kavli Prize ceremony and symposia: Sept. 8-11 (Oslo, Norway)

... (California Institute of Technology, USA). Topic: Kavli Laureate Lecture NANOSCIENCE (alphabetically listed) Thomas Ebbesen (Louis pasteur University, France). Topic: "What is Nanoscience?" Boris Altshuler (Columbia University, USA):"What is Special about Quantum Mechanics at ...

Prix Galien USA Announces 2008 Final Candidates

... -- Nycomed - Omnaris -- Pfizer Inc. - Selzentry(TM) -- Roche Laboratories Inc. - Boniva(R) -- sanofi-aventis - Lovenox(R) -- Sanofi pasteur - H5N1 influenza virus vaccine -- Sucampo Pharmaceuticals, Inc. - Amitiza(R) -- Wyeth - Infuse/InductOs (rh BMP-2 dibotermin alfa) ...

U.S. FDA Licenses DAPTACEL(R) Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series

... of vaccine in 2007, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates ...

Spectral announces 2007 financial results

... Toraymyxin blood purification device. - Entered into a non-exclusive license and material supply agreement in November 2007 with Bio-Rad pasteur S.A., a leader in the manufacturing and distribution of products for the life science research and clinical diagnostics markets. Spectral ...

NPS Pharmaceuticals Announces Senior Management Changes

... Marion Roussel and its predecessor companies. Before joining Hoechst Marion Roussel, Dr. Nader served as head of global commercial operations at the pasteur Vaccines division of Rhone-Poulenc. Conference Call Information A conference call will be held today at 10:00 a.m. Eastern Time. To participate ...

Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs

... Trinity College, Dublin; the Vrije University Medical Center; Weizmann Institute of Science; University of Dundee School of Medicine; the Institute pasteur Korea; and the Institute of Molecular and Cell Biology, a member of A*Star Biomedical Sciences Institutes in Singapore; The Institute of Molecular ...

ExonHit Builds A New Organisation

... as Vice President, Marketing for Gen-Probe, was Director of Marketing at Centocor and held sales and marketing positions with Sanofi Diagnostics pasteur and Abbott Laboratories. Mr. Douglas has experience in cardiovascular, oncology and infectious disease diagnostics. He joins the company as Vice ...

Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors

... Bioscience. Mr. Clarke began his pharmaceutical career at Merck, where he held a series of increasingly responsible positions, including President of pasteur Merieux MSD and Vice President of Merck Vaccines. He holds a Bachelor of Science degree and a Master of Arts degree from the University of Calgary. ...

Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur

... could produce a protective immune response against all four virus subtypes with a single vaccine candidate. "We are pleased to work with sanofi pasteur to address this significant world health problem," said Russell Howard, chief executive officer of Maxygen. "This agreement will allow Maxygen's ...

NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors

... genetic disorder neurofibromatosis and related sporadic tumors, today announced that it has entered into a definitive agreement with Universite Louis pasteur (ULP) and the Centre National de la Recherche Scientifique (CNRS) to in-license a novel family of Hsp90 inhibitors. "Our preliminary evaluation of ...

UW researchers win award from Apple Computer

... scientists with equipment that will help them continue their research. Out of hundreds of applicants, the judges two from BioTeam, one from the pasteur Institute and one from Stockholm University chose five winners. The other four winners were Deborah Dean of the Childrens Hospital Oakland ...

A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors)

... SCIEX acknowledges Hlne Belva-Besnet and Bruno Casetta, and our collaborators Maryse Gravier, Yves Tavet and Didier Olichon from Laboratoire pasteur Cerba, Cergy Pontoise, France, for providing the method, samples and data for this application note. ...

t-HUVEC

... cell suspension to stand in the cuvette for 10 minutes at room temperature. Carefully transfer the cell suspension with a pasteur pipette from the cuvette into 3 ml RPMI / 10% FCS, and cultivate it in a 55 mm culture dish. ...

Escherichia coli DH5

... Immediately add 1 ml SOC medium and transfer to a sterile culture tube with a pasteur pipette. Incubate 30- 60 minutes with moderate shaking at 37 C. Plate on LB plates containing the appropriate selection ...

Escherichia coli DH10B

... Immediately add 1 ml SOC medium and transfer to a sterile culture tube with a pasteur pipette. Incubate 30- 60 minutes with moderate shaking at 37 C. Plate on LB plates containing the appropriate selection ...

Escherichia coli K12

... Immediately add 1 ml SOC medium and transfer to a sterile culture tube with a pasteur pipette. Incubate 30- 60 minutes with moderate shaking at 37 C. Plate on LB plates containing the appropriate selection ...

Escherichia coli C600

... Immediately add 1 ml SOC medium and transfer to a sterile culture tube with a pasteur pipette. Incubate 30- 60 minutes with moderate shaking at 37 C. Plate on LB plates containing the appropriate selection ...

B16

... cell suspension to stand in the cuvette for 15 minutes at room temperature. Carefully transfer the cell suspension with a pasteur pipette from the cuvette into 3 ml DMEM /10% FCS, and cultivate them in a 55 mm culture dish. ...

721.82

... cell suspension to stand in the cuvette for 15 minutes at room temperature. Carefully transfer the cell suspension with a pasteur pipette from the cuvette into 3 ml RPMI /10% FCS, and cultivate them in a 55 mm culture dish. ...